FI20075245A0 - Menetelmä oksidatiivisen metabolian arvioimiseksi - Google Patents

Menetelmä oksidatiivisen metabolian arvioimiseksi

Info

Publication number
FI20075245A0
FI20075245A0 FI20075245A FI20075245A FI20075245A0 FI 20075245 A0 FI20075245 A0 FI 20075245A0 FI 20075245 A FI20075245 A FI 20075245A FI 20075245 A FI20075245 A FI 20075245A FI 20075245 A0 FI20075245 A0 FI 20075245A0
Authority
FI
Finland
Prior art keywords
assessment
oxidative metabolism
oxidative
metabolism
Prior art date
Application number
FI20075245A
Other languages
English (en)
Swedish (sv)
Inventor
Markku Ahotupa
Original Assignee
Markku Ahotupa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Markku Ahotupa filed Critical Markku Ahotupa
Priority to FI20075245A priority Critical patent/FI20075245A0/fi
Publication of FI20075245A0 publication Critical patent/FI20075245A0/fi
Priority to EP08736823A priority patent/EP2142664A4/en
Priority to US12/595,379 priority patent/US8039263B2/en
Priority to PCT/FI2008/050174 priority patent/WO2008125724A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
FI20075245A 2007-04-11 2007-04-11 Menetelmä oksidatiivisen metabolian arvioimiseksi FI20075245A0 (fi)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI20075245A FI20075245A0 (fi) 2007-04-11 2007-04-11 Menetelmä oksidatiivisen metabolian arvioimiseksi
EP08736823A EP2142664A4 (en) 2007-04-11 2008-04-09 ESTIMATION AND BIOLOGICAL CONSEQUENCES OF OXIDATIVE METABOLISM
US12/595,379 US8039263B2 (en) 2007-04-11 2008-04-09 Estimation and biological consequences of oxidative metabolism
PCT/FI2008/050174 WO2008125724A1 (en) 2007-04-11 2008-04-09 Estimation and biological consequences of oxidative metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075245A FI20075245A0 (fi) 2007-04-11 2007-04-11 Menetelmä oksidatiivisen metabolian arvioimiseksi

Publications (1)

Publication Number Publication Date
FI20075245A0 true FI20075245A0 (fi) 2007-04-11

Family

ID=38009898

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075245A FI20075245A0 (fi) 2007-04-11 2007-04-11 Menetelmä oksidatiivisen metabolian arvioimiseksi

Country Status (4)

Country Link
US (1) US8039263B2 (fi)
EP (1) EP2142664A4 (fi)
FI (1) FI20075245A0 (fi)
WO (1) WO2008125724A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016517883A (ja) * 2013-05-03 2016-06-20 オレゴン ヘルス アンド サイエンス ユニバーシティー Ｘ連鎖副腎白質ジストロフィーの処置におけるソベチロムの使用
SG11201706729SA (en) 2015-02-20 2017-09-28 Univ Oregon Health & Science Derivatives of sobetirome
JP6779776B2 (ja) * 2016-06-15 2020-11-04 サンスター株式会社 酸化ｈｄｌの測定方法、及び酸化ｈｄｌ測定用キット
EP3894383A1 (en) 2018-12-12 2021-10-20 Autobahn Therapeutics, Inc. Novel thyromimetics
CA3130371A1 (en) 2019-03-01 2020-09-10 Autobahn Therapeutics, Inc. Novel thyromimetics
JP7189537B2 (ja) * 2019-06-27 2022-12-14 サンスター株式会社 血液試料の酸化ｈｄｌ量の反映値を測定する工程を含む、測定方法
JP6703175B1 (ja) * 2019-09-10 2020-06-03 デンカ生研株式会社 キットおよび方法
WO2021200797A1 (ja) * 2020-03-30 2021-10-07 国立大学法人信州大学 変性ｈｄｌの定量方法、及びそれに用いる分析用試薬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3436444B2 (ja) * 1995-07-21 2003-08-11 ヤマサ醤油株式会社 酸化ｈｄｌの測定法及びキット
US5874313A (en) * 1997-03-25 1999-02-23 Oy Aboatech Ab Method for quantifying oxidation parameters of low density lipoproteins and use thereof
US6596544B1 (en) * 2000-03-31 2003-07-22 The Regents Of The University Of California Functional assay of high-density lipoprotein
KR20040025931A (ko) * 2001-07-12 2004-03-26 교와 메덱스 가부시키가이샤 변성 리포단백질의 정량법, 변성 리포단백질의 정량용시약, 순환기 질환의 검출방법 및 순환기 질환의 검출시약
JP3998245B2 (ja) 2002-03-19 2007-10-24 ヤマサ醤油株式会社 酸化アポリポタンパク質ａｉ及びそれを含有する酸化リポタンパク質の測定法及びキット
US7781219B2 (en) 2003-12-05 2010-08-24 The Cleveland Clinic Foundation Risk markers for cardiovascular disease
CA2581929C (en) 2004-07-19 2016-10-18 University Of Washington Methods for assessing the risk for development of cardiovascular disease

Also Published As

Publication number Publication date
WO2008125724A1 (en) 2008-10-23
US20100055796A1 (en) 2010-03-04
EP2142664A4 (en) 2010-06-02
US8039263B2 (en) 2011-10-18
EP2142664A1 (en) 2010-01-13

Similar Documents

Publication Publication Date Title
CY2017016I1 (el) Αναστολεις πρωτεασωματος
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
BRPI0919116A2 (pt) método
DK2273984T3 (da) Lipidsammensætning
EP2238752A4 (en) IMPROVEMENTS FOR ONE APPLICATION
DK2288375T3 (da) Pegylerede insulin-lispro-forbindelser
DK2080901T3 (da) Vindmølle-vindmålings-kompensation
DK2151833T3 (da) Transformersystem
BRPI0920707A2 (pt) compostos
DK2242759T3 (da) Forbindelser
DK2313489T3 (da) Fremstillingsmetode
BRPI0816914A2 (pt) Método de compensação de elevação
DK2244628T3 (da) Patientdata-sensorapparat
BRPI0721469A2 (pt) Plataforma autoelevatória
BRPI0909160A2 (pt) rolamentos
DK2297162T3 (da) Forbindelser
DK2310613T3 (da) Forbedret brudled til stigrør
DE112009000730A5 (de) Gleitlager
BRPI0809678A2 (pt) Métodos
FI20075245A0 (fi) Menetelmä oksidatiivisen metabolian arvioimiseksi
BRPI0916432A2 (pt) compostos
BRPI0916597A2 (pt) Método
BRPI0810416A2 (pt) Método de hidroformação

Legal Events

Date Code Title Description
FD Application lapsed